The increasing incidence of neuroendocrine forms of prostate cancer

A newly published analysis by a research team at Southern Illinois University School of Medicine has teased out some additional information about the well-recognized increase in the incidence of neuroendocrine forms of prostate cancer over the past 20 or so years. … READ MORE …

A possible chemotherapy for small cell carcinoma of the prostate?

Small cell carcinoma of the prostate or SCCP is a rare, aggressive, and treatment-refractory form of prostate cancer. No good form of treatment is yet known for this disease, and median survival from initial diagnosis is less than 2 years. … READ MORE …

Intraductal carcinoma of the prostate (IDCP)

Intraductal carcinoma of the prostate is occasionally (but rarely) diagnosed on prostate biopsy and is more commonly evident in radical prostatectomy specimens. Basically, this is a type of prostate cancer in which malignant epithelial cells fill large acini and prostatic ducts, and has other specific pathological features. … READ MORE …

The risk posed by ductal carcinoma in patients with prostate cancer

A  paper from an Australian pathology group has suggested that, “Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.” … READ MORE …

The Tuesday news reports: March 31, 2009

In today’s news there are reports on:

  • Initial diagnosis of intraductal carcinoma of the prostate
  • An aborted trial of HIFU using the Ablatherm device
  • Late rectal complications after prostate brachytherapy … READ MORE …